Timeliness of childhood vaccinations in the Philippines

Peter Francis Raguindin1,2, Merrylle Morales-Dizon3, Josephine Aldaba3

  • 1Institute of Child Health and Human Development, National Institutes of Health - University of the Philippines Manila, Manila, Philippines. pnraguindin@up.edu.ph.

Insights

Infant vaccination timeliness in the Philippines shows significant delays. Many infants received vaccines like Penta 3 much later than recommended, impacting routine immunization programs.

Area of Science:

  • Public Health
  • Pediatrics
  • Vaccinology

Background:

  • Routine immunization programs often overlook vaccination timeliness.
  • Monitoring vaccine receipt timing is crucial for disease prevention in infants.

Purpose of the Study:

  • To assess the timeliness of infant vaccinations in the Philippines.
  • To identify delays in vaccine receipt within a routine immunization program.

Main Methods:

  • A review of infant immunizations and caregiver interviews were conducted.
  • Data was collected from 986 infants across 30 public health centers in the Philippines (Jan-Oct 2016).
  • Timeliness was defined as vaccine receipt within 4 weeks of the recommended age.

Main Results:

  • Median vaccine receipt ages were 2.7 weeks (BCG), 10.1 weeks (Penta 1), and 21.7 weeks (Penta 3) against recommendations of 0, 6, and 14 weeks.
  • Timely vaccination rates were 74.4% for BCG, 70.3% for Penta 1, and only 39.1% for Penta 3.
  • Substantial delays in vaccine receipt were observed across multiple antigens.

Conclusions:

  • Infants in the Philippines experience significant delays in receiving routine vaccinations.
  • These delays, alongside declining immunization coverage, pose a risk to infant health.
  • Improving vaccination timeliness monitoring is essential for effective immunization programs.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
49.3K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
109
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
107
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
586
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
132
Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
1.5K